 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

Current Price	$35.70
Prev Close	$33.00
Open	$34.66
Dividend Yield	0.00%
50-Day Moving Average	$34.40
Beta	1.30
Avg. Volume	449,174.58
PE Ratio	-7.20

52-Week High	$53.95
52-Week Low	$20.98
Market Capitalization	$3B
EPS	-$4.28
Price to Book	2.96
Revenue Per Employee	$113,513.75
Enterprise Value/EBITDA	-6.08

ZLAB Zai Lab Ltd

About

Feed

Fundamentals

News